Item 7. Management’s Discussion and Analysis
Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations
This information should
be read in conjunction with the financial statements and notes included in Item 15 of Part IV of this annual report on Form 10-K (this
“Form 10-K”). This Form 10-K contains “forward-looking statements” within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Exchange Act, and such forward-looking statements involve risks and uncertainties. All
statements (other than statements of historical fact) included in this Form 10-K that address activities, events or developments that
may occur in the future, the Trust’s operations, the Sponsor’s plans and references to the Trust’s future success and
other similar matters are forward-looking statements. Words such as “could,” “would,” “may,” “expect,”
“intend,” “estimate,” “predict,” and variations on such words or negatives thereof, and similar expressions
that reflect our current views with respect to future events and Trust performance, are intended to identify such forward-looking statements.
These forward-looking statements are only predictions, subject to risks and uncertainties that are difficult to predict and many of which
are outside of our control, and actual results could differ materially from those discussed. Forward-looking statements involve risks
and uncertainties that could cause actual results or outcomes to differ materially from those expressed therein. We express our estimates,
expectations, beliefs, and projections in good faith and believe them to have a reasonable basis. However, we make no assurances that
management’s estimates, expectations, beliefs, or projections will be achieved or accomplished. These forward-looking statements
are based on assumptions about many important factors that could cause actual results to differ materially from those in the forward-looking
statements. We do not intend to update any forward-looking statements even if new information becomes available or other events occur
in the future, except as required by the federal securities laws.
Organization and Trust Overview
The Trust is a Delaware statutory
trust, formed on September 5, 2023, pursuant to the DSTA. The Trust operates pursuant to an Amended and Restated Trust Agreement (the
“Trust Agreement”). The Trust is not registered as an investment company under the 1940 Act and is not a commodity pool for
purposes of the CEA. The Trust is managed and controlled by the Sponsor. The Sponsor is a limited liability company formed in the state
of Delaware on June 16, 2021, and is a wholly owned subsidiary of Jura Pentium Inc., whose ultimate parent company is 21co Holdings Limited
(formerly known as Amun Holdings Limited). The Sponsor is not subject to regulation by the CFTC as a commodity pool operator with respect
to the Trust, or a commodity trading advisor with respect to the Trust. The Trust is an exchange-traded fund that issues units of beneficial
interest representing fractional undivided beneficial interests in its net assets that trade on the Exchange. The Shares are listed for
trading on the Exchange under a ticker symbol “CETH”.
The Sponsor served as the
“Seed Capital Investor” to the Trust. On May 1, 2024, the Sponsor, in its capacity as Seed Capital Investor, subject to certain
conditions, purchased 2 Shares at a per-Share price of $50.00 (the “Seed Creation Baskets”). Total proceeds to the Trust from
the sale of these Seed Creation Baskets were $100. Delivery of the Seed Creation Baskets was made on May 1, 2024.
On June 18, 2024 (the “Seed
Capital Purchase Date”), 21Shares US LLC, in its capacity as Seed Capital Investor, purchased the initial Seed Creation Baskets
comprising 20,000 Shares (the “Initial Seed Creation Baskets”). In its capacity as the Seed Capital Investor, 21Shares US
LLC has acted as a statutory underwriter in connection with this purchase. The total proceeds to the Trust from the sale of the Initial
Seed Creation Baskets were $340,739. On June 18, 2024, the Trust purchased ether with the proceeds of the Initial Seed Creation Baskets
by transacting with an Ether Counterparty to acquire ether on behalf of the Trust in exchange for cash provided by 21Shares US LLC in
its capacity as Seed Capital Investor. All ether acquired in connection with the Initial Seed Creation Baskets is held by the ether Custodians.
The Trust’s investment
objective is to seek to track the performance of ether, as measured by the performance of the CME CF Ether-Dollar Reference Rate—New
York Variant, adjusted for the Trust’s expenses and other liabilities. CF Benchmarks Ltd. is the administrator for the Index (the
“Index Provider”). The Index is designed to reflect the performance of ether in U.S. dollars. In seeking to achieve its investment
objective, the Trust holds ether at its Custodians and values its Shares daily based on the Index. The Trust is a passive investment vehicle
and is not a leveraged product. The Sponsor does not actively manage the ether held by the Trust.
The Trust issues Shares only
in Creation Baskets of 10,000 or multiples thereof. Creation Baskets are issued and redeemed in exchange for cash. Individual Shares will
not be redeemed by the Trust but are listed and traded on the Exchange under the ticker symbol “CETH”. The Trust issues Shares
in Creation Baskets on a continuous basis at the applicable NAV per Share on the creation order date.
62
The Trust pays the unitary
Sponsor Fee of 0.21% of the Trust’s ether holdings. The Sponsor Fee is paid by the Trust to the Sponsor as compensation for services
performed under the Trust Agreement. The Sponsor is waiving the entire Sponsor Fee for (i) a six-month period which commenced on July
23, 2024 (the day the Trust’s Shares were initially listed on the Exchange), or (ii) the first $500 million of Trust assets, whichever
comes first. Except for during periods during which the Sponsor Fee is being waived, the Sponsor Fee accrues daily and is payable in ether
weekly in arrears. The Administrator calculates the Sponsor Fee on a daily basis by applying a 0.21% annualized rate to the Trust’s
total ether holdings, and the amount of ether payable in respect of each daily accrual is determined by reference to the Index.
The Trust is an “emerging
growth company” as that term is used in the Securities Act of 1933, as amended (the “Securities Act”), and, as such,
the Trust may elect to comply with certain reduced public company reporting requirements.
The NAV of the Trust is used
by the Trust in its day-to-day operations to measure the net value of the Trust’s assets. The NAV is calculated on each Business
Day and is equal to the aggregate value of the Trust’s assets less its liabilities based on the Index price. In determining the
NAV of the Trust on any Business Day, the Administrator calculates the price of the ether held by the Trust as of 4:00 p.m. ET on such
day. The Administrator also calculates the “NAV per Share” of the Trust, which equals the NAV of the Trust divided by the
number of outstanding Shares.
In addition to calculating
NAV and NAV per Share, for purposes of the Trust’s financial statements, the Trust determines the Principal Market NAV and Principal
Market NAV per Share on each valuation date for such financial statements. The determination of the Principal Market NAV and Principal
Market NAV per Share is identical to the calculation of NAV and NAV per Share, respectively, except that the value of ether is determined
using the fair value of ether based on the price in the ether market that the Trust considers its “principal market” as of
4:00 p.m. ET on the valuation date, rather than using the Index.
NAV and NAV per Share are
not measures calculated in accordance with GAAP and are not intended as substitute for Principal Market and Principal Market NAV per Share,
respectively.
Critical Accounting Estimates
The financial statements and
accompanying notes are prepared in accordance with GAAP. The preparation of these financial statements relies on estimates and assumptions
that impact the Trust’s financial position and results of operations. These estimates and assumptions affect the Trust’s application
of accounting policies. Below is a summary of accounting policies on cash and investment valuation. There were no material estimates involving
a significant level of estimation uncertainty that had or are reasonably likely to have had a material impact on the Trust’s financial
condition used in the preparation of the financial statements. In addition, please refer to Note 2 to the Financial Statements included
in this report for further discussion of the Trust’s accounting policies.
Cash
Cash includes non-interest bearing, non-restricted
cash maintained with one financial institution that does not exceed U.S. federally insured limits.
Investment Valuation
The Trust’s policy is
to value investments held at fair value. The Trust follows the provisions of ASC 820, Fair Value Measurements (“ASC 820”).
ASC 820 provides guidance for determining fair value and requires increased disclosure regarding the inputs to valuation techniques used
to measure fair value. ASC 820 determines fair value to be the price that would be received for ether in a current sale, which assumes
an exit price resulting from an orderly transaction between market participants on the measurement date. ASC 820-10 requires the assumption
that ether is sold in its principal market to market participants (or in the absence of a principal market, the most advantageous market).
The Trust utilizes an exchange
traded price from the Trust’s principal market for ether as of 4:00 p.m. ET on the Trust’s financial statement measurement
date.
Results of Operations
For the period May 1, 2024
(initial seed creation) through December 31, 2024*
The Trust’s net
asset value increased to $16,869,879 on December 31, 2024, primarily from an increase in price of ether and a net increase in the number
of shares outstanding of 1,010,000 from May 1, 2024 (date of initial seeding) to December 31, 2024.
Net realized and change in
unrealized gain on investment in ether for the period May 1, 2024 (date of initial seeding) through December 31, 2024, was $4,386,107
which includes a net change in unrealized appreciation on investment in ether of $1,318,367. Net realized and unrealized gain on investment
in ether for the period was driven by ether price appreciation throughout the year to $3,340.57 per ether as of December 31, 2024. Net
increase in net assets resulting from operations was $4,386,107 for the year ended December 31, 2024, which consisted of a net increase
in the number of shares outstanding and by the aforementioned net realized and change in unrealized gain on investment in ether.
* No prior year comparative period has been provided as this is
the first year of the Trust’s operations.
63
Liquidity and Capital Resources
The Trust is not aware of
any trends, demands, commitments, events, or uncertainties that are reasonably likely to result in material changes to its liquidity needs.
The Trust’s only ordinary recurring expense is the fee paid to the Sponsor at an annual rate of 0.21% of the Trust’s total
ether holdings. The Sponsor agreed to waive the entire Sponsor Fee for (i) a six-month period which commenced on July 23, 2024 (the day
the Trust’s Shares were initially listed on the Exchange), or (ii) the first $500 million of Trust assets, whichever came first.
The six-month waiver period ended on January 23, 2025, at which time the Sponsor began collecting the Sponsor Fee. In exchange for the
Sponsor’s fee, the Sponsor has agreed to assume the ordinary fees and expenses incurred by the Trust, including but not limited
to the following: fees charged by Administrator, the Custodians, Transfer Agent and the Trustee, the Marketing Fee, the Exchange’s
listing fees, typical maintenance and transaction fees of the DTC, SEC registration fees, printing and mailing costs, website fees, tax
reporting fees, audit fees, license fees and expenses, up to $100,000 per annum in ordinary legal fees and expenses. The Sponsor bears
expenses in connection with the Trust’s organization and initial offering costs.
The Sponsor is not required
to pay any extraordinary or non-routine expenses. Extraordinary expenses are fees and expenses which are unexpected or unusual in nature,
such as legal claims and liabilities and litigation costs or indemnification or other unanticipated expenses. Extraordinary fees and expenses
also include material expenses which are not currently anticipated obligations of the Trust. The Trust will be responsible for the payment
of such expenses to the extent any such expenses are incurred. Routine operational, administrative, and other ordinary expenses are not
deemed extraordinary expenses. The Trust will sell ether on an as-needed basis to pay the Sponsor’s fee.
Off-Balance Sheet Arrangements
The Trust does not have any
off-balance sheet arrangements.
Item 7A. Quantitative and Qualitative Disclosures
about Market Risks
We are a smaller reporting
company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this
item.